Strong resistance to reduction of treatment and dispensing charges

Published: 2002-11-05 07:00:00

Updated: 2002-11-05 07:00:00

Business sources say that the recently controversial health insurance's relative utilization report, which was released by the Ministry of Health and Welfare, has run into a strong resistance from the medical and pharmaceutical circles, as there is a consensus in both circles that the government ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK